Shockingly, 1 in 3 people living with dementia don’t have a diagnosis. But an early dementia diagnosis can help people ...

Autumn means political party conference season. Here’s what we learned when speaking to MPs about progress for dementia, as ...

Johnny explains why he is supporting Alzheimer's Research UK with a gift in his Will, after losing his mum, Anita, to ...

Learn what the UK public think about prevention, diagnosis, and treatment for dementia, and how these views are shifting as ...

For World Alzheimer’s Month 2025, we put a spotlight on the dementia diagnosis crisis – and the action needed to solve ...

Trontinemab is a potential new Alzheimer’s drug made by drug company Roche. It's still in development, with a trial due to start in autumn 2025.

People with dementia are at risk of missing out on new treatments if the UK does not improve how it hosts clinical trials, according to a new report from Alzheimer’s Research UK. Urgent reform is ...

Prof Catherine Lawrence, The University of Manchester Prof David Llewelyn, University of Exeter Dr Emma Mead, University of Oxford Dr Tim Rittman, University of Cambridge Prof Jessica Teeling, ...

In January 2023 the UK government announced its plan to publish a Major Conditions Strategy. Interventions set out in the Strategy will aim to alleviate pressure on the health system, as well as ...

Help and support from a dedicated fundraising team. A fundraising pack bursting with hints and tips. A free Alzheimer’s Research UK running vest or technical t-shirt. Access to fundraising materials, ...

Register now to receive your free T-shirt and mile tracker! Raise £30 by 1 October to get a FREE beanie hat! Raise £150 by the end of the challenge to receive a FREE re-usable water bottle as a thank ...

A timely, accurate dementia diagnosis can transform lives. Yet too many people still face long waits, uncertainty, or no diagnosis at all. Our new report amplifies the voices of those at the heart of ...